-transparent.png){kind=logo}
Therapy with CD4 and CD8 monoclonal antibodies was evaluated in dogs which received double-haplotype MHC-mismatched renal allografts. Neither CD4 nor CD8 monoclonal antibodies given alone prolonged allografts survival (creatinine > or = 300 micromol/l) beyond 7 days. However, combined therapy with CD4 and CD8 antibodies given up to day 10 did prolong allograft survival to a median of 14 days. A longer (21 day) course of CD4 and CD8 antibodies did not extend allograft survival further. The effect of prolonged antibody therapy was restricted by the occurrence of both an antiglobulin response and an anaphylactoid reaction to the monoclonal antibody preparation. When the CD4 and CD8 antibodies were combined with a pan-T-cell-depleting Thy-1 antibody, the survival of double-haplotype mismatched allografts was further prolonged (median 16 days). The median survival of single-haplotype mismatched renal allografts on this triple therapy was 21 days, with one surviving to day 36.
C J Watson, and
S P Cobbold, and
H F Davies, and
P R Rebello, and
H Waldmann, and
R Y Calne, and
S M Metcalfe
October 1996,
Clinical transplantation,
C J Watson, and
S P Cobbold, and
H F Davies, and
P R Rebello, and
H Waldmann, and
R Y Calne, and
S M Metcalfe
February 2002,
Journal of the American Society of Nephrology : JASN,
C J Watson, and
S P Cobbold, and
H F Davies, and
P R Rebello, and
H Waldmann, and
R Y Calne, and
S M Metcalfe
July 1979,
Surgery,
C J Watson, and
S P Cobbold, and
H F Davies, and
P R Rebello, and
H Waldmann, and
R Y Calne, and
S M Metcalfe
August 2020,
Monoclonal antibodies in immunodiagnosis and immunotherapy,
C J Watson, and
S P Cobbold, and
H F Davies, and
P R Rebello, and
H Waldmann, and
R Y Calne, and
S M Metcalfe
April 1978,
The Keio journal of medicine,
C J Watson, and
S P Cobbold, and
H F Davies, and
P R Rebello, and
H Waldmann, and
R Y Calne, and
S M Metcalfe
June 1995,
Transplantation proceedings,
C J Watson, and
S P Cobbold, and
H F Davies, and
P R Rebello, and
H Waldmann, and
R Y Calne, and
S M Metcalfe
September 1990,
Transplantation,
C J Watson, and
S P Cobbold, and
H F Davies, and
P R Rebello, and
H Waldmann, and
R Y Calne, and
S M Metcalfe
August 1992,
Journal of autoimmunity,
C J Watson, and
S P Cobbold, and
H F Davies, and
P R Rebello, and
H Waldmann, and
R Y Calne, and
S M Metcalfe
September 1990,
Clinical immunology and immunopathology,
C J Watson, and
S P Cobbold, and
H F Davies, and
P R Rebello, and
H Waldmann, and
R Y Calne, and
S M Metcalfe
January 1988,
Current surgery,
